129833943192031250_376Guangzhou pharmaceutical announced new progress of Guangzhou pharmaceutical group Wang Lao JI case
Guangzhou pharmaceutical (00874), said the company was informed that its controlling shareholder, Guangzhou pharmaceutical group on June 1 and receive an appearance notice issued by the Beijing Municipal first intermediate people's Court of China. According to the notice, the Beijing first intermediate people's Court has accepted the applicant Hong Road (Group), apply for revocation of the China international economic and Trade Arbitration Commission arbitration decision on May 9. Guangzhou Pharmaceutical CorporationWang Lao JI earlier trade marks were in favour. Consultation with the legal opinion of the Guangzhou pharmaceutical group, according to the relevant provisions of the law on arbitration, arbitration system of one Conference final, legally effective from the date of the award. Arbitral award against any party may apply to the Court for revocation of the arbitration award. But the revocation of arbitration decision in the Beijing first intermediate people's CourtBefore the award belongs to the final award of the entry into force
Rift Platinum, its legal validity is not affected. According to the decision of the China international economic and Trade Arbitration Commission
Diablo 3 gold, Hung Road of Guangzhou Pharmaceutical Corporation and signed the "Wang Lao JI" trademark license agreement and the "Wang Lao JI" trademark license contract of the supplementary agreement invalid; Hong Road
TERA Gold, stop using "Wang Lao JI" trademark.
Others:
No comments:
Post a Comment